CN103719987A - 一种螺旋藻保健饮料 - Google Patents
一种螺旋藻保健饮料 Download PDFInfo
- Publication number
- CN103719987A CN103719987A CN201210387939.9A CN201210387939A CN103719987A CN 103719987 A CN103719987 A CN 103719987A CN 201210387939 A CN201210387939 A CN 201210387939A CN 103719987 A CN103719987 A CN 103719987A
- Authority
- CN
- China
- Prior art keywords
- spirulina
- people
- beverage
- water
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 240000002900 Arthrospira platensis Species 0.000 title claims abstract description 52
- 235000016425 Arthrospira platensis Nutrition 0.000 title claims abstract description 52
- 229940082787 spirulina Drugs 0.000 title claims abstract description 52
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 7
- -1 sucrose ester Chemical class 0.000 claims abstract description 5
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 4
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930006000 Sucrose Natural products 0.000 claims abstract description 4
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 4
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 4
- 239000003651 drinking water Substances 0.000 claims abstract description 4
- 235000020188 drinking water Nutrition 0.000 claims abstract description 4
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 4
- 239000004310 lactic acid Substances 0.000 claims abstract description 4
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 4
- 239000005720 sucrose Substances 0.000 claims abstract description 4
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 4
- 239000011718 vitamin C Substances 0.000 claims abstract description 4
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 4
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 4
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 4
- 235000013361 beverage Nutrition 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 6
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 235000013399 edible fruits Nutrition 0.000 claims description 3
- 238000001976 enzyme digestion Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000000265 homogenisation Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 235000019629 palatability Nutrition 0.000 claims description 3
- 239000004576 sand Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 238000009849 vacuum degassing Methods 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract 1
- 235000013734 beta-carotene Nutrition 0.000 abstract 1
- 239000011648 beta-carotene Substances 0.000 abstract 1
- 229960002747 betacarotene Drugs 0.000 abstract 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 108010053210 Phycocyanin Proteins 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000037213 diet Effects 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 229930003451 Vitamin B1 Natural products 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 241000252983 Caecum Species 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 108010052989 Naphthol AS D Esterase Proteins 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000003471 anti-radiation Effects 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 201000005917 gastric ulcer Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 150000002497 iodine compounds Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 231100000417 nephrotoxicity Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 208000017983 photosensitivity disease Diseases 0.000 description 2
- 231100000434 photosensitization Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- NNMALANKTSRILL-ZUTFDUMMSA-N 3-[(2z,5z)-2-[[3-(2-carboxyethyl)-5-[(z)-[(3z,4r)-3-ethylidene-4-methyl-5-oxopyrrolidin-2-ylidene]methyl]-4-methyl-1h-pyrrol-2-yl]methylidene]-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methylpyrrol-3-yl]propanoic acid Chemical compound O=C1C(CC)=C(C)C(\C=C/2C(=C(CCC(O)=O)C(=C/C3=C(C(C)=C(\C=C/4\C(\[C@@H](C)C(=O)N\4)=C/C)N3)CCC(O)=O)/N\2)C)=N1 NNMALANKTSRILL-ZUTFDUMMSA-N 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022971 Iron Deficiencies Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- INPDFIMLLXXDOQ-UHFFFAOYSA-N Phycocyanobilin Natural products CCC1=C(C)C(=CC2=NC(=C/c3[nH]c(C=C/4C(C(C(N4)=O)C)=CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O INPDFIMLLXXDOQ-UHFFFAOYSA-N 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 229940089536 indocin Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000003024 peritoneal macrophage Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010072011 phycocyanobilin Proteins 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及饮料领域,特指一种螺旋藻保健饮料:由螺旋藻0.2-0.3%、白砂糖9-12%、柠檬酸0.08%、乳酸0.02%、维生素C0.02%、葡萄糖酸锌0.02%、蔗糖酯0.06%、乙二胺四乙酸二钠0.02%、β—胡萝卜素0.03%、柠檬香精0.06%、余量饮用水;经过加工所得产品,具有具有能调节人体的生理机能,增强免疫力,又易于消化作用的滋补饮料。
Description
技术领域
本发明涉及饮料领域,特指一种螺旋藻保健饮料。
背景技术
目前,经常出差、忙碌的办公人员、减肥人士或精神压力大、体力透支、免疫力低下、贫血、营养状况不良、饮食不规律的人士很多,针对这些人群,本发明要解决的技术问题是提供一种具有能调节人体的生理机能,增强免疫力,又易于消化作用的滋补饮料。
发明内容
本发明的目的在于,提供一种螺旋藻保健饮料,采用如下技术方案(以1000升成品,原料按重量百分比计):a、螺旋藻0.2-0.3%、白砂糖9-12%、柠檬酸0.08%、乳酸0.02%、维生素C 0.02%、葡萄糖酸锌0.02%、蔗糖酯0.06%、乙二胺四乙酸二钠0.02%、β—胡萝卜素0.03%、柠檬香精0.06%、饮用水备用;b、工艺流程:① 预处理制备螺旋藻浸提液;将螺旋藻加水60kg ,拌匀后调整其pH为11 左右,另配制2 . 5%的酶液,加人2.5kg,控制温度为48-50℃ ,进行6-7h 的酶解反应。随后可加入乙二胺四乙酸二钠等护色剂护色,接着将螺旋藻液入高速离心机,在3500转/分钟 条件下操作15-20分钟,得其清液;② 调配先将白砂搪加l倍温水溶化,再加人其他原料的溶液,混合均匀、再加入螺旋藻液,开动搅拌器搅拌均匀,随后加水定容至1000升;③ 均质、脱气 将混合液人高压均质机均质,均质压力为25-3OMPa,随即用真空脱气机除去饮料中的空气;④ 灌装、杀菌 将饮料用板式换热器加热至60-65℃,趁热灌装入瓶,再人热水中,在100℃温度下杀菌15-20分钟,冷却后即成绿色透明、甜酸适口,具果实风味的螺旋藻保健饮料。
本发明的有益效果是:通过所述配方和生产工艺的接合,得到的具有能调节人体的生理机能,增强免疫力,又易于消化作用的滋补饮料。
螺旋藻的药理作用:
1、抗辐射损伤作用:放射照射前、后给小鼠口服螺旋藻,均能提高小鼠存活率,有效剂量为每只3.75-15mg(156-625mg/kg体重,服用次数2-5次)。螺旋藻预防给药3次,经7.5Gy照射后第9天,对受照射动物敏感器官的观察表明,螺旋藻可使照射小鼠的胸腺重量、骨髓DNA含量高于对照组,这表明螺旋藻对免疫器官和造血组织有保护作用,这可能是螺旋藻抗辐射损伤作用的机制之一。
2、抗菌作用:钝顶螺旋藻对革兰阳性菌有抑菌作用,含脂质和三萜类化合物的钝顶螺旋藻的乙醇提取物抑菌活性最强,含甾醇的提取物也有抑菌作用,但作用较弱。钝顶螺旋藻对革兰阴性菌无抑制作用。
3、抗癌作用:螺旋藻对短期一次注射和长期多次注射1,2-二甲肼诱导的NIH小鼠和标准差大鼠大肠变性隐窝的形成有抑制作用。螺旋藻多糖对体内腹水型肝癌细胞有显着的抑制率,治疗组为54.0%,防治组达91.4%,对癌细胞DNA、RNA和蛋白质的抑制作用均随作用时间延长而加强。
4、光敏作用:用含0.25mg/ml的藻蓝蛋白(藻青素)处理培养的小鼠骨髓瘤细胞,再经514nm激光辐照300J/cm2,发现癌细胞存活率仅15%;而单纯采用激光辐照或藻蓝蛋白处理,细胞存活率为69%和71%。人大肠癌细胞株HR8348培养后分别用100μg,50μg,25μg的钝顶螺旋藻的藻蓝蛋白处理,经光波为630nm的铜激光辐照12J/cm2,用MTT法检测培养癌细胞存活率分别为22.2%,37.6%和89.7%,显示良好的剂量效应。对肉瘤S180小鼠,分别给予藻蓝蛋白注射2mg或口服20mg后,经铜激光辐照瘤体15天后,有效率分别为50%和53%,与对照组相比,具显着差异。体内外试验证实藻蓝蛋白确有光敏作用,且无毒副反应,是一种理想的光敏剂。
5、对免疫***的作用:螺旋藻多糖可使小鼠的血清溶血素提高39.5%-98.0%,腹腔巨噬细胞的吞噬率提高32.5%-51.5%,吞噬指数提高0.9-1.8倍,T淋巴细胞数提高46.8%-87.7%,脾脏白髓淋巴细胞排列密集,红髓内巨噬细胞明显增多,酸性α-乙酸萘酯酯酶(ANAE)阳性淋巴细胞增加7.3%-12.8%。
6、降低胆固醇:将30位高胆固醇、轻度高血脂的男性,分为两组,A组每日服螺旋藻4.2g,持续8星期,血清总胆固醇在4星期内从6.3mmol/L(244mg/dl)降至6.1mmol/L(233mg/dl),降幅达4.5%。B组服4星期便停止,总血清胆固醇降低,后恢复到最初的水平。低密度脂蛋白胆固醇在4星期内显着降低达6.1%,原来高胆固醇水平的人,血清胆固醇降幅更大。
7、提高铁的生物有效性和调理贫血症:选纯种Wistar大鼠,用低铁饮食法复制缺铁性贫血模型,用螺旋藻进行恢复试验,以硫酸亚铁为阳性对照组,以低铁饲料为阴性对照组,按螺旋藻含量由小到大分为3个实验组,含量分别为1%,8%,15%。结果:实验2组和实验3组体重高于阳性对照组,实验1组体重与阳性对照组接近,阳性对照组体重高于阴性对照组。提示单纯性缺铁可影响大鼠生长,致大鼠体重增长缓慢,而螺旋藻有加速大鼠体重增长的作用,对大鼠缺铁性贫血恢复效果显着。另一项在日本进行的试验是,对8名青年妇女较长期限制她们的饮食,显现次长期贫血症--血红蛋白低于正常水平,然后在每顿饭后食用4g螺旋藻,服用80天后,血红蛋白提高21%,从109g/L上升为132g/L,不再贫血。
8、帮助建造健康的乳酸杆菌群:喂饲螺旋藻的老鼠,体内乳酸杆菌含量比对照组增加了3倍。在老鼠饮食中加5%的螺旋藻,饲喂100天,结果为:盲肠的重量增加13%,乳酸杆菌增加327%,盲肠内维生素B1增加43%。螺旋藻没提供这额外的维生素B1,而是改善了整个维生素B1的吸收。说明食用螺旋藻使体内的乳酸杆菌增多,并使机体从饮食中吸收维生素B1和其他维生素的效率提高。
9、对胃的保护作用:钝顶螺旋藻灌胃250-500mg/kg,对吲哚美辛(消炎痛)型、无水乙醇型实验性大鼠胃溃疡模型有明显保护作用;可降低幽门结扎型大鼠溃疡模型的发生率和减少溃疡数,对胃液分泌也有一定的抑制作用;可加速慢性醋酸型大鼠胃溃疡的愈合。
10、减轻汞及药物对肾的毒性:给老鼠注射配制好的高浓度有机汞药物后,表明肾毒性的血液尿素氮(BUN)增加310%,血清肌酸增高198%,在饮食中添加30%的螺旋藻后,BUN下降20%,血清肌酸降低157%,有2例降至最初水平。在给老鼠用了普通药物后,也能观察到类似现象,如镇痛剂、抗生素、抗癌药等。
11、其他作用:用含钝顶螺旋藻的饲料喂养小鸡,能使小鸡体重增加80%,这是由于钝顶螺旋藻内含碘化合物的存在,如T4、T3,这些含碘化合物刺激了小鸡的生长。此外,螺旋藻能使血糖降低,抑制血压上升
具体实施方式
下面结合一较佳实施例对发明做进一步的阐述,本发明提供的技术方案生产工艺步骤如下(以1000升成品,原料按重量百分比计): a、螺旋藻0.3%、白砂糖10%、柠檬酸0.08%、乳酸0.02%、维生素C 0.02%、葡萄糖酸锌0.02%、蔗糖酯0.06%、乙二胺四乙酸二钠0.02%、β—胡萝卜素0.03%、柠檬香精0.06%、饮用水备用;b、工艺流程:① 预处理制备螺旋藻浸提液;将螺旋藻加水60kg ,拌匀后调整其pH为11 左右,另配制2 . 5%的酶液,加人2.5kg,控制温度为48-50℃ ,进行6-7h 的酶解反应。随后可加入乙二胺四乙酸二钠等护色剂护色,接着将螺旋藻液入高速离心机,在3500转/分钟 条件下操作15-20分钟,得其清液;② 调配先将白砂搪加l倍温水溶化,再加人其他原料的溶液,混合均匀、再加入螺旋藻液,开动搅拌器搅拌均匀,随后加水定容至1000升; ③ 均质、脱气 将混合液人高压均质机均质,均质压力为25-3OMPa,随即用真空脱气机除去饮料中的空气;④ 灌装、杀菌 将饮料用板式换热器加热至60-65℃,趁热灌装入瓶,再人热水中,在100℃温度下杀菌15-20分钟,冷却后即成绿色透明、甜酸适口,具果实风味的螺旋藻保健饮料。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何不经过创造性劳动想到的变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应该以权利要求书所限定的保护范围为准。
Claims (1)
1.一种螺旋藻保健饮料,其特征在于,采用如下技术方案(以1000升成品,原料按重量百分比计):a、螺旋藻0.2-0.3%、白砂糖9-12%、柠檬酸0.08%、乳酸0.02%、维生素C 0.02%、葡萄糖酸锌0.02%、蔗糖酯0.06%、乙二胺四乙酸二钠0.02%、β—胡萝卜素0.03%、柠檬香精0.06%、饮用水备用;b、工艺流程:① 预处理制备螺旋藻浸提液;将螺旋藻加水60kg ,拌匀后调整其pH为11 左右,另配制2 . 5%的酶液,加人2.5kg,控制温度为48-50℃ ,进行6-7h 的酶解反应,随后可加入乙二胺四乙酸二钠等护色剂护色,接着将螺旋藻液入高速离心机,在3500转/分钟 条件下操作15-20分钟,得其清液;② 调配先将白砂搪加l倍温水溶化,再加人其他原料的溶液,混合均匀、再加入螺旋藻液,开动搅拌器搅拌均匀,随后加水定容至1000升;③ 均质、脱气 将混合液人高压均质机均质,均质压力为25-3OMPa,随即用真空脱气机除去饮料中的空气;④ 灌装、杀菌 将饮料用板式换热器加热至60-65℃,趁热灌装入瓶,再人热水中,在100℃温度下杀菌15-20分钟,冷却后即成绿色透明、甜酸适口,具果实风味的螺旋藻保健饮料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210387939.9A CN103719987A (zh) | 2012-10-15 | 2012-10-15 | 一种螺旋藻保健饮料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210387939.9A CN103719987A (zh) | 2012-10-15 | 2012-10-15 | 一种螺旋藻保健饮料 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103719987A true CN103719987A (zh) | 2014-04-16 |
Family
ID=50444481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210387939.9A Pending CN103719987A (zh) | 2012-10-15 | 2012-10-15 | 一种螺旋藻保健饮料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103719987A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104522827A (zh) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | 一种藻类酵素营养固体饮品及其制备工艺 |
CN106107374A (zh) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | 一种螺旋藻保健饮品及其制备方法 |
CN111096400A (zh) * | 2019-12-06 | 2020-05-05 | 嗨能天然饮料(广州)有限公司 | 一种螺旋藻保健饮品 |
CN113575827A (zh) * | 2021-07-01 | 2021-11-02 | 杭州娃哈哈科技有限公司 | 一种含类胡萝卜素果汁类饮料的复合护色剂及其应用 |
-
2012
- 2012-10-15 CN CN201210387939.9A patent/CN103719987A/zh active Pending
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104522827A (zh) * | 2014-12-19 | 2015-04-22 | 上海承煌实业有限公司 | 一种藻类酵素营养固体饮品及其制备工艺 |
CN106107374A (zh) * | 2016-07-02 | 2016-11-16 | 威海御膳坊生物科技有限公司 | 一种螺旋藻保健饮品及其制备方法 |
CN111096400A (zh) * | 2019-12-06 | 2020-05-05 | 嗨能天然饮料(广州)有限公司 | 一种螺旋藻保健饮品 |
CN113575827A (zh) * | 2021-07-01 | 2021-11-02 | 杭州娃哈哈科技有限公司 | 一种含类胡萝卜素果汁类饮料的复合护色剂及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101965969B (zh) | 一种具有抗疲劳和提高免疫功能保健食品组合物及其制备方法和用途 | |
CN102273680B (zh) | 一种金针菇多糖复合饮料及其制备方法 | |
CN1275534C (zh) | 玉米肽饮料及其加工方法 | |
CN106172250A (zh) | 一种蜜蜂的繁育方法 | |
CN103103057A (zh) | 一种蚕虫草营养露酒的配制方法 | |
CN103725469A (zh) | 一种养生干红葡萄酒 | |
CN103719987A (zh) | 一种螺旋藻保健饮料 | |
CN101991165A (zh) | 红薯叶-紫苏叶复合饮料及其制备方法 | |
CN104304679A (zh) | 一种复合维生素c、e免疫多糖微乳液制剂及其制备方法和应用 | |
CN103436419B (zh) | 一种用蚝制备的保健酒及其制备方法 | |
CN107007646A (zh) | 一种辅助防治癌症的营养复合物 | |
CN104686806A (zh) | 一种增强肉鸡免疫力的复合饲料添加剂 | |
CN107961260A (zh) | 治疗、预防禽类大肠杆菌性腹泻病的药剂及其制备方法 | |
CN102379391A (zh) | 松花粉葡聚糖纳豆保健食品的制备 | |
CN101961067A (zh) | 一种新型肉鸡饲料添加剂 | |
CN101053437B (zh) | 一种有机锗Ge-132灵芝饮料及制备方法 | |
CN101589743A (zh) | 一种含益生元的西瓜汁营养奶 | |
CN104509748A (zh) | 一种鸡饲料添加剂及其制备方法 | |
CN107897588A (zh) | 黑参蒜功能饮料及其制备方法 | |
CN107502509A (zh) | 一种低酒精含量覆盆子保健酒饮料及其制备方法 | |
CN103690962B (zh) | 一种犬自主采食型药物载体及其制备方法 | |
CN105767997A (zh) | 一种蜂花粉及其制备方法 | |
CN101045899B (zh) | 一种有机锗Ge-132灵芝酒及制备方法 | |
CN101731591A (zh) | 蜂胶蜜膏及制备方法 | |
CN104187658B (zh) | 鸽保健口服液及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140416 |